Gene · 2010
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The regulatory role of the nuclear scaffold protein Emerin on the migration of amniotic epithelial cells and oxidative stress in a pressure environment. | Placenta | 2025 | 40245600 | PubTator, text mining | PubMed |
| Downregulation of Nesprin1 by Runx2 deficiency is critical for the development of skeletal laminopathy-like pathology. | Proc Natl Acad Sci U S A | 2025 | 40208950 | PubTator, text mining | PubMed |
| Cell surface display of a protein based on a tail-anchored membrane protein. | Biochem Biophys Res Commun | 2025 | 40184792 | PubTator, text mining | PubMed |
| The role of inner nuclear membrane protein emerin in myogenesis. | FASEB J | 2025 | 40178931 | PubTator, text mining | PubMed |
| TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer. | Cell Death Dis | 2025 | 40159489 | PubTator, text mining | PubMed |
| Pulsatile flow induces chromatin interaction with lamin-associated proteins to enrich H3K9 methylation in endothelial cells. | Proc Natl Acad Sci U S A | 2025 | 40117319 | PubTator, text mining | PubMed |
| EMD missense variant causes X-linked isolated dilated cardiomyopathy with myocardial emerin deficiency. | Eur J Hum Genet | 2025 | 40065010 | Swiss-Prot, curated | PubMed |
| Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer. | Clin Cancer Res | 2025 | 40063516 | PubTator, text mining | PubMed |
| Human iPSC-Derived Muscle Cells as a New Model for Investigation of EDMD1 Pathogenesis. | Int J Mol Sci | 2025 | 40004006 | PubTator, text mining | PubMed |
| Matrix deformation and mechanotransduction as markers of breast cancer cell phenotype alteration at matrix interfaces. | Biomater Sci | 2025 | 39960148 | PubTator, text mining | PubMed |
| Lamin A and Emerin Protein Expression Remains Consistently Low and Nuclear Size is Unchanged in Normal Endometrium, Precancerous Lesions, and Endometrioid Carcinoma. | Int J Gynecol Pathol | 2025 | 39479965 | PubTator, text mining | PubMed |
| Optimized simple culture protocol for inducing mature myotubes from MYOD1-overexpressed human iPS cells. | Sci Rep | 2024 | 39567611 | PubTator, text mining | PubMed |
| A Review of Muscular Dystrophies. | Anesth Prog | 2024 | 39503119 | PubTator, text mining | PubMed |
| Unveiling the roles of LEMD proteins in cellular processes. | Life Sci | 2024 | 39374771 | PubTator, text mining | PubMed |
| Nuclear envelope budding inhibition slows down progerin-induced aging process. | Proc Natl Acad Sci U S A | 2024 | 39352925 | PubTator, text mining | PubMed |
| Lamin chromatin binding is modulated by interactions of different LAP2α domains with lamins and chromatin. | iScience | 2024 | 39319273 | PubTator, text mining | PubMed |
| Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment. | Exp Mol Med | 2024 | 39218980 | PubTator, text mining | PubMed |
| Emerin deficiency drives MCF7 cells to an invasive phenotype. | Sci Rep | 2024 | 39198511 | PubTator, text mining | PubMed |
| Effect of lamins and emerin on nuclear morphology and histological architecture in lung adenocarcinoma. | Pathol Res Pract | 2024 | 39191195 | PubTator, text mining | PubMed |
| Altered expression and localization of nuclear envelope proteins in a prostate cancer cell system. | Mol Biol Rep | 2024 | 39115711 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2010/papers?page=4